Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection
Phase 1
Not yet recruiting
- Conditions
- Vulvovaginal CandidiasisBacterial Vaginosis
- Interventions
- Other: PLACEBO
- First Posted Date
- 2024-06-10
- Last Posted Date
- 2024-06-12
- Lead Sponsor
- NEXBIOME THERAPEUTICS
- Target Recruit Count
- 165
- Registration Number
- NCT06450990
© Copyright 2025. All Rights Reserved by MedPath